Latest Breaking News On - Pharmaceuticals trading down - Page 17 : comparemela.com

Raymond James & Associates Has $133 24 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Raymond James & Associates lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 6.9% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 318,757 shares of the pharmaceutical company’s stock after selling 23,660 shares during the period. Raymond James & Associates owned approximately […]

Ourania tatsisChevy chase trust holdingsNews ratings for vertex pharmaceuticals dailyVertex pharmaceuticals trading downCanaccord genuity groupQuarter for vertex pharmaceuticalsVertex pharmaceuticalsVertex pharmaceuticals profileRaymond james associatesJpmorgan chase coVertex pharmaceuticals incorporatedSecurities exchange commissionAtlantic union bankshares corpRaymond jamesFree reportUnion bankshares corp

Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Price Target at $195 08

Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average twelve-month target […]

United statesPhilipl johnsonPatricia carrRobertw bairdInsider transactions at jazz pharmaceuticalsCantor fitzgeraldNews ratings for jazz pharmaceuticals dailyJpmorgan chase coJazz pharmaceuticalsNeedham companyAnalyst recommendations for jazz pharmaceuticalsDaiwa securities group incCapital investment advisorsWaterfront wealth incRoyal bankAllspring global investments holdings

X4 Pharmaceuticals (XFOR) to Release Quarterly Earnings on Tuesday

X4 Pharmaceuticals (XFOR) to Release Quarterly Earnings on Tuesday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Paula raganAdams mostafaSecurities exchange commissionPharmaceuticals dailyPharmaceuticals trading downPharmaceuticals incGet free reportTrading downExchange commission

Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up to $21 30

Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up to $21 30
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdNews ratings for longboard pharmaceuticals dailyLongboard pharmaceuticals company profileAsset management incJennison associatesLongboard pharmaceuticals incLongboard pharmaceuticalsPolar capital holdings plcPlatinum investment management ltdCantor fitzgeraldParkman healthcare partnersLongboard pharmaceuticals trading downGet free reportPharmaceuticals trading downCapital holdings plcHealthcare partners

ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Rating Reaffirmed by Cantor Fitzgerald

ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts at Cantor Fitzgerald in a research report issued on Tuesday, Benzinga reports. They presently have a $37.00 target price on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target would indicate a potential upside of 118.16% from the stock’s […]

United statesStephen davisJames kiharaLegato capital managementPharmaceuticals trading downPharmaceuticals dailyCantor fitzgeraldChina universal asset management coSecurities exchange commissionAcadian asset managementQuest partnersPharmaceuticals incRoyal bankAcadia pharmaceuticalsGet free reportTrading down